These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 20191092)

  • 21. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.
    Angelina A; Pérez-Diego M; López-Abente J; Rückert B; Nombela I; Akdis M; Martín-Fontecha M; Akdis C; Palomares O
    Mucosal Immunol; 2022 Jan; 15(1):96-108. PubMed ID: 34548620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canine immune cells express high levels of CB
    Brown C; Mitsch M; Blankenship K; Campbell C; Pelanne M; Sears J; Bell A; Olivier AK; Ross MK; Archer T; Kaplan BLF
    Vet Immunol Immunopathol; 2023 Nov; 265():110667. PubMed ID: 37931433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptors and their endogenous agonist, anandamide.
    Axelrod J; Felder CC
    Neurochem Res; 1998 May; 23(5):575-81. PubMed ID: 9566594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
    Karanian DA; Bahr BA
    Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
    García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids and autoimmune diseases: A systematic review.
    Katchan V; David P; Shoenfeld Y
    Autoimmun Rev; 2016 Jun; 15(6):513-28. PubMed ID: 26876387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling via CNS cannabinoid receptors.
    Mackie K
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S60-5. PubMed ID: 18336996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.
    Ahmed I; Rehman SU; Shahmohamadnejad S; Zia MA; Ahmad M; Saeed MM; Akram Z; Iqbal HMN; Liu Q
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34205169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
    Pertwee RG
    Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
    Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocannabinoids and immune regulation.
    Pandey R; Mousawy K; Nagarkatti M; Nagarkatti P
    Pharmacol Res; 2009 Aug; 60(2):85-92. PubMed ID: 19428268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
    Kicman A; Pędzińska-Betiuk A; Kozłowska H
    Eur J Pharmacol; 2021 Nov; 911():174560. PubMed ID: 34648805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.
    An D; Peigneur S; Hendrickx LA; Tytgat J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.
    Lowin T; Schneider M; Pongratz G
    Curr Opin Rheumatol; 2019 May; 31(3):271-278. PubMed ID: 30920973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.